Oil for Life to Balance omega-3 polyunsaturated fatty acids ... - Oil4Life

� Leitzmann M.F., Stampfer M.J., Michaud D.S., Augustsson K., Colditz G.C.,
Willet W.C. et al. (2004) Dietary intake of n-3 and n-6 fatty acid and the risk of
prostate cancer. Am. J. Clin. Nutr. 80: 204– 16.
� Lemon P.W.R. (2000) Beyond the zone: Protein needs of active individuals. J. Am.
Coll. Nutr. 19: 513– 21.
� Leventhal L.J., Boyce E.G., Zurier R.B. (1993) Treatment of rheumatoid arthritis
with gammalinolenic acid. Ann. Intern. Med. 119: 867-873.
� Liu S., Willet W.C. (2002) Dietary glycemic load and atherothrombotic risk. Cur.r
AtherosclerRe.p 4: 454– 61.
� London S.J., Sacks F.M., Caesar J., Stampfer M.J., Siguel E., Willett W.C.
(1991). Fatty acid composition of subcutaneous adipose tissue and diet in
postmenopausal US women. Am. J. Clin. Nutr. 54: 340–345.
� Lòpez Mata P., Ortega R.M. (2003) Omega-3 fatty acids in the prevention and
control of cardiovascular disease. Eur. J. Clin. Nutr. 57: 22– 5.
� Ludwig D.S. (2002) Physiological mechanisms relating to obesity, diabetes, and
cardiovascular disease. JAMA 287: 2414– 23.
� Ma J, Folsom R, Lewis L, Eckfeldt H. (1997) Relation of plasma phospholipids and
cholesterol ester fatty acid composition to carotid artery intima-media thickness: the
atherosclerosis risk in communities (ARIC) study. Am. J. Clin. Nutr. 65: 551-559.
� Manku M.S., Horrobin D.F., Morse N.L. (1984) Essential fatty acids in the plasma
phospholipids of patients with atopic eczema. Br. J. Dermatol. 110: 643-648.
� Marckmann P., Lassen A., Haraldsdóttir J., Sandström B. (1995). Biomarkers of
habitual fish intake in adipose tissue. Am. J. Clin. Nutr. 62: . 956–959.
� Markovic T.P., Campbell L.V., Balasubramanian S., Jenkins A.B., Fleury A.C.,
Simons L.A. et al. (1998) Beneficial effect on average lipid levels from energy
restriction and fat loss in obese individuals with or without type 2 diabetes. Diabetes
Care 21: 695– 700.
� Mathers C.D., Sadana R., Salomon J.A., Murray C.J.L., Lopez A.D. (2001)
Healthy life expectancy in 191 countries 1999. Lancet 357: 1685– 91.
� Matorras R., Perteagudo L., Sanjurjo P., Ruiz J. (1999) The intake of long chain
n-3 PUFA during pregnancy and their levels in the mother influence the new-born
levels. Eur. J. Obstet. Gynecol. Reprod. Biol. 83: 179-189.
� Matorras R., Ruiz J., Perteagudo L., Barbazan M.J, Diaz A., Velladoid A.,
Sanjurjo P. (2001) Longitudinal study of fatty acids in plasma and erythrocyte
phospholipids during pregnancy. J. Perinat. Med. 29: 293-297.
� McKarney C., Everard M., N’Diaye T. (2007) Omega-3 fatty acids (from fish oils)
for cystic fibrosis. Cochrane Database Syst. Rew. 17; (4):CD002201.
� Millberger S., Biederman J., Faraone S.V., Chen L., Jones J. (1996) Is maternal
smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in
children? Am. J. Psychiatry 153: 1138-1142.
� Miller A., Berrino F., Hill M., Pietnen P., Piboli E., Wahrendorf J. (1990) Diet in
the aetiology of cancer: a review. Eur. J. Cancer 30: 207-220.
� Mischoulon D., Fava M. (2000) Docosahexanoic acid and n-3 fatty acids in
depression. Psychiat. Clin. North Am. 23: 785– 94.
� Murray R.K. Granner D.K., Mayes P.A., Rodwell V.W. (2003). Harper’s
Illustrated Biochemistry. 23: 195-96.
� Neff L.M. (2003) Evidence-based dietary recommendations for patients with type 2
diabetes mellitus. Nutr. Clin. Care 6: 51– 61.
42